A Minimalist Design Looks Great for Clearing Tau
Interception of Extracellular Tau by Antibodies May Be Sufficient to Stop the Spread of Tau in AD
Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
For full access to this article login to GEN Select now.
Embryonic Stem Cells: Not Just From Humans
New Applications Promise to Boost Drug Development and Manufacturing
- Until recently, almost all the talk about stem cells revolved around the use of human embryonic stem (ES) cells as a therapeutic modality. Now, noted Majid Mehtali, Ph.D., CSO of Vivalis (www.vivalis.com), there is a growing realization that other mammalian and avian ES cells offer good utility in areas ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.